Skip to main content
SpringerLink
Log in

Prostate Carcinoma

  • Chapter
  • First Online:
Histopathology Reporting

  • 791 Accesses

Abstract

Prostate Carcinoma: this chapter outlines the incidence, risk factors, clinical presentation, investigations, treatments and prognosis of cancer at this anatomical site. These features are correlated with the core data that are required to make corresponding histopathology reports of a consistently high quality, available in an appropriate timeframe, and clinically relevant to patient management and prognosis. Summary details of the common cancers given at this site include: gross description, histological types, tumour grade/differentiation, extent of local tumour spread, lymphovascular invasion, lymph node involvement, and the status of excision margins. Current WHO Classifications of Malignant Tumours and TNM8 are referenced. Notes are provided on other associated pathology, contemporary use of immunohistochemistry, updates on the role of evolving molecular tests, and the use of these ancillary techniques as biomarkers in diagnosis, and prediction of prognosis and treatment response. A summary is given of the more common non-carcinoma malignancies that are encountered at this site in diagnostic practice.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 159.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Amin MB, Eptsein JI, Ulbright TM, et al. Best practices recommendations in the application of immunohistochemistry in urologic pathology. Am J Surg Pathol. 2014;38:1017–22.

    Article  Google Scholar 

  • Bennett VS, Varma M, Bailey DM. Guidelines for the macroscopic processing of radical prostatectomy and pelvic lymphadenectomy specimens. J Clin Pathol. 2008;61:713–21.

    Article  Google Scholar 

  • Cheng L, Montironi R, Bostwick DG, Lopez-Beltran A, Berney DM. Staging of prostate cancer. Histopathology. 2012;60:87–117.

    Article  Google Scholar 

  • Doud N, Li G, Evans AJ, van der Kwast TH. The value of triple antibody (34βE12 + p63 + AMACR) cocktail stain in radical prostatectomy specimens with crushed surgical margins. J Clin Pathol. 2012;65:437–40.

    Article  Google Scholar 

  • Epstein JI. Diagnosis of limited adenocarcinoma of the prostate. Histopathology. 2012;60:28–40.

    Article  Google Scholar 

  • Epstein JI. Prostate cancer grading: a decade after the 2005 modified system. Mod Pathol. 2018;31:S47–63.

    Article  Google Scholar 

  • Epstein JI, Egvad L, Amin MB, Delahunt B, et al. The 2014 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016a;40:244–52.

    PubMed  Google Scholar 

  • Epstein JI, Zelefsky MJ, Sjoberg DD, et al. A contemporary prostate cancer grading system: a validated alternative to the Gleason score. Eur Urol. 2016b;69:428–35.

    Article  Google Scholar 

  • Epstein JI, Egevad L, Amin MB. The 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma: definition of grading patterns and proposal for a new grading system. Am J Surg Pathol. 2016c;40:244–52.

    PubMed  Google Scholar 

  • Epstein JI, Amin MB, Reuter VE, Humphrey PA. Contemporary gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 International Society of Urological Pathology (ISUP) consensus conference on gleason grading of prostatic carcinoma. Am J Surg Pathol. 2017a;41:e1–7.

    Article  Google Scholar 

  • Epstein JI, Amin MB, Reuter VE. Contemporary gleason grading of prostatic carcinoma: an update with discussion on practical issues to implement the 2014 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol. 2017b;41:e1–7.

    Article  Google Scholar 

  • Gleason D. Histologic grading and clinical staging of prostatic carcinoma. In: Tannenbaum M, editor. Urologic pathology. The prostate. Philadelphia, PA: Lea and Febiger; 1977. p. 171–98.

    Google Scholar 

  • Hendriks RJ, van Oort IM, Schalken JA. Blood-based and urinary prostate cancer biomarkers: a review and comparison of novel biomarkers for detection and treatment decisions. Prostate Cancer Prostatic Dis. 2017;20:12–9.

    Article  CAS  Google Scholar 

  • Humphrey PA, Moch H, Cubilla AL, Ulbright TM, Reuter VE. The 2016 WHO classification of tumours of the urinary system and male genital organs-part B: prostate and bladder tumours. Eur Urol. 2016;70:106–19.

    Article  Google Scholar 

  • Kench JG, Delahunt B, Griffiths DF, Humphrey PA, McGowan T, Trpkov K, Varma M, Wheeler TM, Srigley JR. Dataset for reporting of prostate carcinoma in radical prostatectomy specimens: recommendations from the International collaboration on cancer reporting. Histopathology. 2013;62:203–18.

    Article  Google Scholar 

  • Kristiansen G. Diagnostic and prognostic molecular biomarkers for prostate cancer. Histopathology. 2012;60:125–41.

    Article  Google Scholar 

  • Mathieu R, Moschini M, Beyer B. Prognostic value of the new grade groups in prostate cancer: a multi-institutional European validation study. Prostate Cancer Prostatic Dis. 2017;20:197–202.

    Article  CAS  Google Scholar 

  • Moch H, Humphrey PA, Ulbright TM, Reuter VE, editors. WHO classification of tumors of the urinary system and male genital organs. 4th ed. Lyon: IARC; 2016.

    Google Scholar 

  • Montironi R, Scarpelli M, Mazzucchelli R, Cheng L, Lopez-Beltran A. The spectrum of morphology in non-neoplastic prostate including cancer mimics. Histopathology. 2012;60:41–58.

    Article  Google Scholar 

  • Paner GP, Aron M, Hansel DE, Amin AB. Non-epithelial neoplasms of the prostate. Histopathology. 2012;60:166–86.

    Article  Google Scholar 

  • Pierorazio PM, Walsh PC, Partin AW. Prognostic Gleason grade grouping: data based on the modified Gleason scoring system. BJU Int. 2013;111:753–60.

    Article  Google Scholar 

  • Prendeville S, Gertner M, Maganti M. Role of magnetic resonance imaging targeted biopsy in detection of prostate cancer harboring adverse pathological features of intraductal carcinoma and invasive cribriform carcinoma. J Urol. 2018;S0022–5347:30175–7.

    Google Scholar 

  • Rubin MA, Girelli G, Demichelis F. Genomic correlates to the newly proposed grading prognostic groups for prostate cancer. Eur Urol. 2016;69:557–60.

    Article  Google Scholar 

  • Srigley JR, Delahunt B, Evans AJ. Therapy-associated effects in the prostate gland. Histopathology. 2012;60:153–65.

    Article  Google Scholar 

  • The Royal College of Pathologists. Standards and datasets for reporting cancers Dataset for histopathology reports for prostatic carcinoma. 2016. https://www.rcpath.org/profession/guidelines/cancer-datasets-and-tissue-pathways.html.

  • Truong M, Feng C, Hollenberg G. A comprehensive analysis of cribriform morphology on magnetic resonance imaging/ultrasound fusion biopsy correlated with radical prostatectomy specimens. J Urol. 2018;199:106–13.

    Article  Google Scholar 

  • Vainer B, Toft BG, Olsen KE, Jacobsen GK, Marcussen N. Handling of radical prostatectomy specimens: total or partial embedding? Histopathology. 2011;58:211–6.

    Article  Google Scholar 

  • Van der Kwast Th H, Lopes C, Santonja C, Pihl C-G, Neetens I, Martikainen P, Di Lollo S, Bubendolf L, Hoedemaeker RF, Members of the Pathology Committee of the European Randomised Study of Screening for Prostate Cancer (ERSPC). Guidelines for processing and reporting of prostatic needle biopsies. J Clin Pathol. 2003;56:336–40.

    Article  Google Scholar 

  • Varma M, Egevad L, Delahunt B, Kristiansen G. Reporting intraductal carcinoma of the prostate: a plea for greater standardization. Histopathology. 2016;70:504–7.

    Article  Google Scholar 

  • Wobker SE, Epstein JI. Differential diagnosis of intraductal lesions of the prostate. Am J Surg Pathol. 2016;40:e67–82.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Pathology, Royal Victoria Hospital, Belfast, UK

    Declan O’Rourke

Authors
  1. Declan O’Rourke
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Declan O’Rourke .

Editor information

Editors and Affiliations

  1. Institute of Pathology, Royal Victoria Hospital, Belfast, UK

    David P. Boyle

  2. Belfast City Hospital Histopathology Laboratory, Belfast, UK

    Derek C. Allen

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

O’Rourke, D. (2020). Prostate Carcinoma. In: Boyle, D., Allen, D. (eds) Histopathology Reporting. Springer, Cham. https://doi.org/10.1007/978-3-030-27828-1_31

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-27828-1_31

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-27827-4

  • Online ISBN: 978-3-030-27828-1

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation